Journal
JOURNAL OF NEUROCHEMISTRY
Volume 105, Issue 2, Pages 308-323Publisher
WILEY
DOI: 10.1111/j.1471-4159.2007.05131.x
Keywords
allosteric modulator; cerebellum; cortex; G protein; GABA(B) receptors; hippocapus; scintillation proximity assay
Categories
Ask authors/readers for more resources
Little is known concerning coupling of cerebral GABA(B) receptors to G protein subtypes, and the influence of positive allosteric modulators (PAMs) has not been evaluated. These questions were addressed by an antibody-capture/scintillation proximity assay strategy. GABA concentration-dependently enhanced the magnitude of [S-35]GTP gamma S binding to G alpha o and, less markedly, G alpha i(1/3) in cortex, whereas Gq and Gs/olf were unaffected. (R)-baclofen and SKF97581 likewise activated G alpha o and G alpha i(1/3), expressing their actions more potently than GABA. Similar findings were acquired in hippocampus and cerebellum, and the GABA(B) antagonist, CGP55845A, abolished agonist-induced activation of G alpha o and G alpha i(1/3) in all structures. The PAMs, GS39783, CGP7930 and CGP13501, inactive alone, enhanced efficacy and potency of agonist-induced [S-35]GTP gamma S binding to G alpha o in all regions, actions abolished by CGP55845A. In contrast, they did not modify efficacies at G alpha i(1/3). Similarly, in human embryonic kidney cells expressing GABA(B(1a+2)) or GABA(B(1b+2)) receptors, allosteric modulators did not detectably enhance efficacy of GABA at G alpha i(1/3), though they increased its potency. To summarise, GABA(B) receptors coupled both to G alpha o and to G alpha i, but not Gq and Gs/olf, in rat brain. PAMs more markedly enhanced efficacy of coupling to Go versus Gi(1/3). It will be of interest to confirm these observations employing complementary techniques and to evaluate their potential therapeutic significance.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available